3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase 3
4
Phase 1/2
3
Phase NA
2
Phase 4
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
2012
Carcinoma, Non-Small-Cell Lung
1227
Breast Neoplasms
1215
Leukemia, Myeloid, Acute
967
Neoplasm Metastasis
902
Melanoma
777
Colorectal Neoplasms
751
Multiple Myeloma
725
Lymphoma
725
Ovarian Neoplasms
675
Pancreatic Neoplasms
665
Lymphoma, Non-Hodgkin
659
Prostatic Neoplasms
657
Recurrence
636
Precursor Cell Lymphoblastic Leukemia-Lymphoma
585
Lung Neoplasms
560
Leukemia, Lymphocytic, Chronic, B-Cell
555
Glioblastoma
527
Leukemia
486
Lymphoma, Large B-Cell, Diffuse
440
Lymphoma, Follicular
418
Brain Neoplasms
414
Squamous Cell Carcinoma of Head and Neck
389
Stomach Neoplasms
387
Carcinoma, Renal Cell
385
Myelodysplastic Syndromes
382
Carcinoma, Hepatocellular
368
Advanced Solid Tumors
357
Lymphoma, Mantle-Cell
345
Glioma
342
Interventions
darolutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Interventional
×
Male Urogenital Diseases
×
Clear all
NCT07103018
2026-03-23
STRIKE-001
K36 Therapeutics, Inc.
Phase 1
Recruiting
144 enrolled